APSARD: American Professional Society of ADHD and Related Disorders

The prevalence of attention-deficit/hyperactivity disorder (ADHD) identified in an outpatient sample of 492 adults seeking mental health treatment was nearly 10 times higher than the prevalence identified in epidemiological studies, according to a poster presented at the recent 2018 Annual Meeting of The American Professional Society of ADHD and Related Disorders.

Attention-deficit/hyperactivity disorder (ADHD) is a recognized disorder affecting both children and adults, but what is known about ADHD when it affects older adults, especially those nearing retirement age or those who are already retired? Kathleen G. Nadeau, PhD, is surveying this special population for research for an upcoming book. Nadeau, a psychologist in Maryland, spoke about this issue at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders.

Can improved research designs answer questions that come up between doctors and patients, like better understanding the risks and benefits of prescription medicine for attention-deficit/hyperactivity disorder (ADHD)? Brian M. D'Onofrio, PhD, presented about translational epidemiology in a talk called The Risks and Benefits of ADHD: A Pharmacoepidemiologic Perspecitive to answer those questions at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders (APSARD).

Psychologist J. Russell Ramsay, PhD, presented at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders about his model for understanding and treating adult attention-deficit/hyperactivity disorder (ADHD) with cognitive-behavioral therapy (CBT) in his session, "Intentions into Actions: CBT for Adult ADHD."

A large proportion of caregivers with children and adolescents diagnosed with attention-deficit/hyperactivity-disorder (ADHD) perceived that the burden of illness remained high even if the children are on current prescription drug therapy, according to a poster presented at the 2018 Annual Meeting of The American Professional Society of ADHD and Related Disorders in Washington, DC.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo